brello glp-1 Discover if You Qualify for Brello's Plans WEEKLY GLP-1 Update! Week 7

Reimann F

While Vyvanse can help those with binge eating disorder lose weight, its not a weight loss drug

Wilson JM et al (2020) The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes

Providing the exact medication name, dose, and duration of use helps staff give you accurate information rather than generic answers

The answer is yes, some lean mass loss can occur during weight loss, but this is largely influenced by nutrition, protein intake, and resistance training rather than the medication itself